Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+136K
-
Total reported value, excl. options
-
$2.27B
-
Value change
-
+$17.4M
-
Number of buys
-
100
-
Number of sells
-
-87
-
Price
-
$120.56
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2014
229 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2014.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.8M shares), VANGUARD GROUP INC (1.21M shares), ARIEL INVESTMENTS, LLC (1.06M shares), LEVIN CAPITAL STRATEGIES, L.P. (837K shares), WELLS FARGO & COMPANY/MN (704K shares), BlackRock Fund Advisors (653K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (562K shares), NWQ INVESTMENT MANAGEMENT COMPANY, LLC (558K shares), BlackRock Institutional Trust Company, N.A. (556K shares), and State Street Corp (554K shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.